SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,244,000 | -29.4% | 200,000 | -33.3% | 3.24% | -30.8% |
| Q2 2023 | $34,356,000 | +13.3% | 300,000 | +36.4% | 4.67% | +7.7% |
| Q1 2023 | $30,322,600 | +6.4% | 220,000 | 0.0% | 4.34% | +29.9% |
| Q4 2022 | $28,507,600 | -26.3% | 220,000 | -37.1% | 3.34% | -29.8% |
| Q3 2022 | $38,689,000 | +29.0% | 350,000 | -12.5% | 4.76% | -13.5% |
| Q2 2022 | $29,984,000 | -22.4% | 400,000 | +45.5% | 5.50% | +11.3% |
| Q3 2020 | $38,618,000 | +110.7% | 275,000 | +46.8% | 4.94% | -29.1% |
| Q1 2020 | $18,327,000 | -37.2% | 187,350 | -17.1% | 6.97% | -3.0% |
| Q4 2019 | $29,163,000 | – | 226,002 | – | 7.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |